Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+31.92%
adds when stocks drop
when a holding falls −10%+
Middle response
+1.14%
steady accumulation
Rally response
-64.14%
trims into rallies
when a holding rises +10%+
Top positions · 30
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| — | $97M | 30.9% | — | 0.3 yr |
| TNGXTango Therapeutics, Inc. | $11M | 3.3% | — | 0.5 yr |
| RVMDRevolution Medicines, In | $8M | 2.5% | — | 0.5 yr |
| TYRATyra Biosciences, Inc. | $7M | 2.4% | — | 0.5 yr |
| LQDALiquidia Corporation | $7M | 2.3% | — | 0.5 yr |
| AGIOAgios Pharmaceuticals, I | $7M | 2.2% | — | 0.5 yr |
| IPSCCentury Therapeutics, In | $7M | 2.1% | — | 0.3 yr |
| ELVNEnliven Therapeutics, In | $6M | 2.0% | — | 0.5 yr |
| PCVXVaxcyte, Inc. | $6M | 2.0% | — | 0.5 yr |
| — | $6M | 2.0% | — | 0.3 yr |
| COGTCogent Biosciences, Inc. | $6M | 1.8% | — | 0.5 yr |
| — | $5M | 1.7% | — | 0.3 yr |
| — | $5M | 1.7% | — | 0.3 yr |
| CGONCG Oncology, Inc. Common | $5M | 1.6% | — | 0.5 yr |
| PHVSPharvaris N.V. | $5M | 1.5% | — | 0.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology49.7%$157M
Unknown49.2%$155M
Medical - Devices0.5%$2M
Medical - Care Facilities0.3%$1M
Drug Manufacturers - General0.2%$1M
Drug Manufacturers - Specialty & Generic0.1%$0M
Medical - Pharmaceuticals0.0%$0M
Country
Unknown49.2%
US44.6%
FR1.9%
GB1.7%
NL1.5%
CN0.5%
IE0.4%
CA0.1%
Top 5: 41.4% · Top 10: 51.8% · Top 25: 72.5%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 15
| IPSC Century Therapeutics, Inc.new | +$7M |
| AGIO Agios Pharmaceuticals, Inc. | +$6M |
| TNGX Tango Therapeutics, Inc. | +$6M |
| PCVX Vaxcyte, Inc. | +$5M |
| TYRA Tyra Biosciences, Inc. | +$4M |
| LQDA Liquidia Corporation | +$4M |
| ERAS Erasca, Inc.new | +$4M |
| ROIV Roivant Sciences Ltd.new | +$4M |
| CYTK Cytokinetics, Incorporated | +$3M |
| DNTH Dianthus Therapeutics, Inc. | +$3M |
Top sells this quarter · 15
| CGON CG Oncology, Inc. Common stock | −$97M |
| EXEL Exelixis, Inc.exit | −$3M |
| COGT Cogent Biosciences, Inc. | −$2M |
| BLTE Belite Bio, Incexit | −$1M |
| DYN Dyne Therapeutics, Inc.exit | −$1M |
| FOLD Amicus Therapeutics, Inc.exit | −$1M |
| NUVL Nuvalent, Inc. | −$1M |
| RLMD Relmada Therapeutics, Inc.exit | −$1M |
| NKTR Nektar Therapeutics | −$1M |
| MBX MBX Biosciences, Inc. Common Sexit | −$1M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $315M | 114 | +38.32% | -4.37% | +42.69% | +0.11B |
| 2025-12-31 | $148M | 85 | — | — | — | — |